U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  1. About Science & Research at FDA

FDA Grand Rounds

FDA Grand Rounds

The FDA Grand Rounds is an educational presentation that is webcast monthly to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities. The 45-minute educational presentation is followed by questions from the audience. You can also view the presentation under Past Grand Rounds following the live webcast. #FDAGrandRounds.

Upcoming Event

FDA Grand Rounds - FDA’s Color Certification Program - Regulation and Research

Thursday, June 13, 2024
12:00 p.m. - 1:00 p.m. ET
Webcast

About the Speaker

Bhakti Petigara Harp, Ph.D.
Research Chemist 
Office of Cosmetics and Colors (OCAC)
Center for Food Safety and Applied Nutrition (CFSAN)
U. S. Food and Drug Administration (FDA)

Dr. Bhakti Petigara Harp has been with FDA's Office of Cosmetics and Colors (OCAC) in the Center for Food Safety and Applied Nutrition (CFSAN) as a research chemist since 2000. Her current responsibilities include research and methods development for color additives and other components using various analytical techniques for the agency’s color certification program. She also is a technical expert and troubleshooter to support the FDA district laboratories in regulatory actions concerning the analysis of atypical samples of food, drugs and cosmetics containing organic color additives. In addition, Bhakti performs chemistry reviews of data establishing chemical identity, composition, stability, and manufacture of color additives submitted in support of color additive petitions. Bhakti earned her B.S. in Chemistry from Franklin and Marshall College in Lancaster, Pennsylvania.  She earned her Ph.D. in Chemistry from University of Maryland in College Park, MD. 

Past Grand Rounds

2024

2023

2022

2021

2020

2019

2018

2017

2016

Resources For You


Sub-Topic Paragraphs

Latest From the Commissioner

Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices - 05/22/2024

May 22

FDA Statement from Todd Simpson, FDA Chief Information Officer (CIO) on GAO Report Regarding FDA’s IT Security Program

Sep 29

Statement by FDA Commissioner Scott Gottlieb, M.D. on new steps by FDA to advance patient engagement in the agency’s regulatory work

Feb 28

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Dec 07

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Jun 12

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug

Jun 28

Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety

Sep 14

Statement from FDA Commissioner Scott Gottlieb, M.D., and Center for Devices and Radiological Health Director Jeff Shuren, M.D., J.D., on agency efforts to work with tech industry to spur innovation in digital health

Sep 12


Back to Top